<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Sgp — News on 6ix</title>
    <link>https://6ix.com/company/sgp</link>
    <description>Latest news and press releases for Sgp on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 26 Mar 2026 04:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/sgp" rel="self" type="application/rss+xml" />
    <item>
      <title>SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 Earnings and Provides a Corporate Update</title>
      <link>https://6ix.com/company/sgp/news/spyglass-pharma-reports-fourth-quarter-and-full-year-2025-earnings-and-provides-a-corporate-update</link>
      <guid isPermaLink="true">https://6ix.com/company/sgp/news/spyglass-pharma-reports-fourth-quarter-and-full-year-2025-earnings-and-provides-a-corporate-update</guid>
      <pubDate>Thu, 26 Mar 2026 04:00:00 GMT</pubDate>
      <description>Successfully completed Initial Public Offering (IPO) in February 2026, raising $172.5 million and listing on Nasdaq.Reported positive topline 12-month data</description>
    </item>
    <item>
      <title>SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative BIM-IOL System</title>
      <link>https://6ix.com/company/sgp/news/spyglass-pharma-announces-positive-topline-12-month-phase-12-trial-results-for-its-innovative-bim-iol-system</link>
      <guid isPermaLink="true">https://6ix.com/company/sgp/news/spyglass-pharma-announces-positive-topline-12-month-phase-12-trial-results-for-its-innovative-bim-iol-system</guid>
      <pubDate>Mon, 09 Mar 2026 04:00:00 GMT</pubDate>
      <description>97% of patients who received the BIM-IOL System off all topical IOP-lowering therapy at 12-months100% of BIM-IOL System patients achieved 20/32 or better</description>
    </item>
    <item>
      <title>SpyGlass Pharma to Participate in the Jefferies Biotech on the Beach Summit</title>
      <link>https://6ix.com/company/sgp/news/spyglass-pharma-to-participate-in-the-jefferies-biotech-on-the-beach-summit-6</link>
      <guid isPermaLink="true">https://6ix.com/company/sgp/news/spyglass-pharma-to-participate-in-the-jefferies-biotech-on-the-beach-summit-6</guid>
      <pubDate>Wed, 04 Mar 2026 05:00:00 GMT</pubDate>
      <description>ALISO VIEJO, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma”), a late-stage biopharmaceutical company, today</description>
    </item>
    <item>
      <title>SpyGlass Pharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares</title>
      <link>https://6ix.com/company/sgp/news/spyglass-pharma-announces-closing-of-initial-public-offering-and-exercise-in-full-of-the-underwriters-option-to-purchase-additional-shares</link>
      <guid isPermaLink="true">https://6ix.com/company/sgp/news/spyglass-pharma-announces-closing-of-initial-public-offering-and-exercise-in-full-of-the-underwriters-option-to-purchase-additional-shares</guid>
      <pubDate>Mon, 09 Feb 2026 05:00:00 GMT</pubDate>
      <description>ALISO VIEJO, Calif., Feb. 09, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma”), a late-stage biopharmaceutical company, today</description>
    </item>
    <item>
      <title>SpyGlass Pharma Announces Pricing of Initial Public Offering</title>
      <link>https://6ix.com/company/sgp/news/spyglass-pharma-announces-pricing-of-initial-public-offering</link>
      <guid isPermaLink="true">https://6ix.com/company/sgp/news/spyglass-pharma-announces-pricing-of-initial-public-offering</guid>
      <pubDate>Thu, 05 Feb 2026 05:00:00 GMT</pubDate>
      <description>ALISO VIEJO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma”), a late-stage biopharmaceutical company, today</description>
    </item>
  </channel>
</rss>